Avantax Planning Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.48M | Buy |
|
|||||
|
2025
Q1 | $6.58M | Buy |
|
|||||
|
2024
Q4 | $6.57M | Sell |
|
|||||
|
2024
Q3 | $7.7M | Sell |
|
|||||
|
2024
Q2 | $9.59M | Buy |
|
|||||
|
2024
Q1 | $9.05M | Buy |
|
|||||
|
2023
Q4 | $4.09M | Sell |
|
|||||
|
2023
Q3 | $4.89M | Buy |
|
|||||
|
2023
Q2 | $4.8M | Buy |
|
|||||
|
2023
Q1 | $5.24M | Sell |
|
|||||
|
2022
Q4 | $6.62M | Sell |
|
|||||
|
2022
Q3 | $5.78M | Buy |
|
|||||
|
2022
Q2 | $6.77M | Buy |
|
|||||
|
2022
Q1 | $6.17M | Buy |
|
|||||
|
2021
Q4 | $5.89M | Sell |
|
|||||
|
2021
Q3 | $5.07M | Sell |
|
|||||
|
2021
Q2 | $4.66M | Buy |
|
|||||
|
2021
Q1 | $4.28M | Sell |
|
|||||
|
2020
Q4 | $4.63M | Sell |
|
|||||
|
2020
Q3 | $4.93M | Sell |
|
|||||
|
2020
Q2 | $4.39M | Buy |
|
|||||
|
2020
Q1 | $3.94M | Buy |
|
|||||
|
2019
Q4 | $3.95M | Sell |
|
|||||
|
2019
Q3 | $3.77M | Buy |
|
|||||
|
2019
Q2 | $4.09M | Buy |
|
|||||
|
2019
Q1 | $3.78M | Buy |
|
|||||
|
2018
Q4 | $3.24M | Buy |
|
|||||
|
2018
Q3 | $3.12M | Buy |
|
|||||
|
2018
Q2 | $2.39M | Sell |
|
|||||
|
2018
Q1 | $2.53M | Sell |
|
|||||
|
2017
Q4 | $2.6M | Sell |
|
|||||
|
2017
Q3 | $3.63M | Sell |
|
|||||
|
2017
Q2 | $3.55M | Buy |
|
|||||
|
2017
Q1 | $3.42M | Buy |
|
|||||
|
2016
Q4 | $3.19M | Buy |
|